首页> 美国卫生研究院文献>Clinical and Applied Thrombosis/Hemostasis >Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis
【2h】

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis

机译:血小板与淋巴细胞比率和中性粒细胞与淋巴细胞比率是静脉血栓形成的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) are associated with an increased risk of arterial thrombosis, but their role in venous thromboembolism (VTE) has not been fully investigated. A case–control study, of 486 patients with VTE, 100 with cerebral vein thrombosis (CVT), and 299 healthy individuals, was carried out to investigate whether high PLR or NLR values are associated with an increased risk of VTE. Patients with high PLR or NLR did not have an increased risk of VTE (odds ratio [OR] 0.89, 95% confidence interval [CI]: 0.46-1.76; OR: 0.69, 95% CI: 0.34-1.39, respectively) or CVT (OR: 1.65, 95% CI: 0.68-4.00; OR: 0.39, 95% CI: 0.09-1.72, respectively). Subgroups analysis showed that high PLR values were associated with the risk of provoked CVT (OR: 2.65, 95% CI: 1.02-6.92), and there was an interaction with thrombophilia abnormalities (OR: 7.67, 95% CI: 1.67-35.27) in patients with CVT. In conclusion, high PLR and NLR values are not associated with an overall increased risk of VTE or CVT. High PLR values increase the risk of provoked CVT and interact with thrombophilia abnormalities in patients with CVT.
机译:高血小板与淋巴细胞比率(PLR)和中性白细胞与淋巴细胞比率(NLR)与动脉血栓形成的风险增加相关,但尚未充分研究其在静脉血栓栓塞(VTE)中的作用。进行了一项病例对照研究,调查了486例VTE,100例脑静脉血栓形成(CVT)和299例健康个体,以调查高PLR或NLR值是否与VTE风险增加相关。高PLR或NLR的患者没有增加VTE的风险(赔率[OR]为0.89,95%置信区间[CI]:0.46-1.76; OR:0.69,95%CI:0.34-1.39) (或:分别为:1.65,95%CI:0.68-4.00;或:0.39,95%CI:0.09-1.72)。亚组分析显示,高PLR值与诱发CVT的风险相关(OR:2.65,95%CI:1.02-6.92),并且与血友病异常有相互作用(OR:7.67,95%CI:1.67-35.27) CVT患者中。总之,较高的PLR和NLR值与增加的VTE或CVT风险无关。高PLR值会增加CVT患者引发CVT的风险,并与血友病异常相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号